Page 534 - Adams and Stashak's Lameness in Horses, 7th Edition
P. 534

500   Chapter 4


              In the animal demonstrating renal compromise or   Therapy Regarding Matrix Metalloprotease Inhibition
            clinical signs of GI ulceration, ketoprofen is indicated   Although many practitioners have used tetracyclines
  VetBooks.ir  toxin effects and lameness 4,57  and a markedly increased   in laminitis cases based on the drugs’ reported MMP
            due to its reported efficacy in ameliorating both endo-
                                                               inhibitory properties, preliminary data from an equine
            margin of safety when compared with flunixin or
                49
            PBZ.  Due to the poor response when the drug is only   study indicate that doxycycline is a poor inhibitor of
                                                               equine MMPs of interest (MMP‐2 and MMP‐9) and
            administered BID and the incredible safety of the drug,   oxytetracycline inhibits MMPs in vitro but was ineffec-
            the BID dosage of ketoprofen can be administered QID   tive in treating the disease in a model of laminitis.
                                                                                                              33
            (2.2 mg/kg IV QID). Since a “peak and trough” analge-  Additionally, further studies have decreased the interest
            sic effect between ketoprofen dosages has been observed   in MMPs as a therapeutic target including (1) a study
            in some animals, it may be prudent to administer   demonstrating that MMP‐2 and MMP‐9 were neither in
            2.2 mg/kg PBZ SID in order to have a more consistent   an active state in lamellar extracts from clinical cases of
            NSAID effect.                                      laminitis  and (2) the inability to block lamellar pathol-
                                                                       48
              Analgesia in the chronic case most commonly con-
            sists of PBZ therapy, with long‐term doses usually in   ogy with marimastat—a potent broad‐spectrum MMP
                                                               inhibitor—in using an experimental model of laminitis
            the range of 2.2–4.4 mg/kg/day to avoid complica-  (Underwood and Pollitt, personal communication).
            tions. An important reason for PBZ’s higher incidence
            of toxicity when compared with the other NSAIDs
            (almost every reported case of NSAID‐related right   Drugs Affecting Blood Flow
            dorsal colon ulceration has been due to PBZ) is that
            the drug has a longer half‐life and accumulates in the   The majority of drugs that have been introduced
            tissues to a much greater degree than either flunixin   for treatment of possible decreased lamellar blood
            or ketoprofen. One way to avoid toxicity in animals   flow have been demonstrated to be ineffective in
            on long‐term PBZ therapy is to cease administration   increasing lamellar blood flow in the horse (i.e. isox-
            of the drug for 24 hours once every 5–7 days to allow   suprine, pentoxifylline, and nitroglycerin paste). The
            clearance of PBZ from the system. If the animals are   only drug    demonstrated to increase digital blood
            too painful to be without an NSAID for 24 hours,   flow is the phenothiazine tranquilizer acepromazine,
            either ketoprofen or flunixin may be given without   which only increases flow for a short period of time
            interfering with the clearance of PBZ. Firocoxib has   (approximately 30 minutes) when administered
            the advantage of once‐a‐day treatment and is much   intramuscularly. 45
            more protective against GI concerns than PBZ; how-
            ever, in the authors’ opinion, it commonly does not   Anticoagulant Therapy
            provide an adequate amount of analgesia in many
            laminitis cases.                                      Although there are data supporting the role of plate-
                                                                          2
              Pentoxifylline is reported to be anti‐inflammatory   lets in SRL,  there is no consensus on the use of any
                                    3
            due to its “anti‐TNF” effect ; preliminary results from a   therapies to address this area. There are confounding
            study using the carbohydrate model indicate a decreased   data from retrospective clinical studies on the efficacy of
            incidence of lamellar failure in animals with pentoxifyl-  heparin as a prophylaxis in horses at risk of laminitis. 8,13
            line therapy initiated at the time of intragastric adminis-  Furthermore, experimental treatment with heparin 24
            tration  of carbohydrate.   It is  unknown whether  the   hours after carbohydrate overload (CHO) administra-
                                 17
            efficacy is due to inhibition of inflammatory signaling,   tion did not ameliorate signs of laminitis or lamellar
                                                                      50
            inhibition of matrix metalloproteases, or any hemor-  lesions.  One problem with previous heparin studies is
            rheologic effect (not likely as requires prolonged therapy   that unfractionated heparin was used, which induces
            to achieve this effect in other species). Although digital   autoagglutination of equine red blood cells and becomes
            hypothermia (“cryotherapy”) has been demonstrated to   lodged in capillaries (including lamellar capillaries); this
            protect the lamellae from structural failure when insti-  event may further compromise affected lamellar capil-
            tuted at multiple time point in models of SRL (discussed   laries  in laminitis.  Low molecular  weight  heaparin
            below), 18,20,24,25  it has a variable effect on inhibition of   (LMWH) may be a valuable alternative because it
            inflammatory signaling depending on when it has been   does not cause equine RBC autoagglutination and
            instituted. 15,16,20  Hypothermia has an inhibitory effect on   has recently been reported to reduce the incidence
                                                                                                              61
            a broad array of inflammatory molecules (multiple   and   severity of laminitis in postoperative colic cases.
            cytokines and chemokines, adhesion molecules, COX‐2)   Unfortunately, no further studies have been published
            if initiated prior to the administration of a carbohydrate   on LMWH in laminitis in the past decade.
                    24
            overload,  but a much more focused effect (primarily
            IL‐6 and COX‐2) when initiated later in the disease process   Analgesic Therapy
            (onset of sepsis),  and, when instituted at the onset of lame-
                         16
            ness, no consistent anti-inflammatory effect (although still   The mainstay of analgesic therapy in laminitis cases is
            protective against lamellar failure).  Although intrave-  still the use of NSAIDs. Whereas PBZ is still the NSAID
                                          15
            nous lidocaine infusion, similar to that used for treat-  providing the greatest analgesia in the laminitic horse exhib-
            ment of ileus in the equine patient, has been proposed as   iting digital pain, flunixin meglumine or COX‐2 selective
            a treatment to decrease inflammatory signaling in lami-  NSAIDs (e.g. firocoxib) may be used if there are ongoing
            nitis, no anti‐inflammatory and actually some proin-  systemic concerns in which the other NSAIDs may either be
            flammatory properties of constant rate intravenous   more effective or less harmful (i.e. concomitant renal disease

            lidocaine infusion were reported in a laminitis model. 72  or GI ulceration, ongoing endotoxemia).
   529   530   531   532   533   534   535   536   537   538   539